Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance

December 20, 2015 at 4:49 pm

Clinical Infectious Diseases SEP 15, 2015 V.61 Suppl.2 S58-S68

James A. Karlowsky, Kim Nichol, and George G. Zhanel

1Department of Medical Microbiology, College of Medicine, University of Manitoba

2Diagnostic Services Manitoba, Winnipeg, Canada

Correspondence: George G. Zhanel, PhD, Clinical Microbiology, Health Sciences Centre, MS673-820 Sherbrook St, Winnipeg, Manitoba R3A 1R9, Canada (ggzhanel@pcs.mb.ca).

Telavancin is a semisynthetic lipoglycopeptide derivative of vancomycin. Telavancin has a dual mechanism of antibacterial action, disrupting peptidoglycan synthesis and cell membrane function. In 2014, the Clinical and Laboratory Standards Institute (CLSI) revised the antimicrobial susceptibility testing method for telavancin, resulting in minimum inhibitory concentration (MIC) determinations that are more accurate and reproducible and demonstrate greater in vitro potency than shown with the previous testing method. The CLSI testing method changes coincided with revised telavancin MIC interpretive break point criteria for susceptibility approved by the US Food and Drug Administration for Staphylococcus aureus (≤0.12 µg/mL), Streptococcus pyogenes (≤0.12 µg/mL), Streptococcus agalactiae (≤0.12 µg/mL), Streptococcus anginosus group (≤0.06 µg/mL), and Enterococcus faecalis (vancomycin susceptible, ≤0.25 µg/mL). Telavancin is equally potent against methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). It demonstrates activity against isolates of heterogeneous vancomycin-intermediate S. aureus and vancomycin-intermediate S. aureus but is poorly active against vancomycin-resistant S. aureus. It also demonstrates potent activity against Staphylococcus epidermidis and Streptococcus spp. (MIC90 ≤0.03 µg/mL). Thus far, it has not been possible to select for high-level telavancin resistance in the laboratory using serially passaged clinical isolates of MRSA and MSSA.

PDF

http://cid.oxfordjournals.org/content/61/suppl_2/S58.full.pdf

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Metodos diagnosticos, Resistencia bacteriana, Sepsis, Update. Tags: .

Mixed infection in adult post-neurosurgical bacterial meningitis: a hospital-based study. Skin and Soft-Tissue Infections: A Critical Review and the Role of Telavancin in Their Treatment


Calendar

December 2015
M T W T F S S
« Nov   Jan »
 123456
78910111213
14151617181920
21222324252627
28293031  

Most Recent Posts


%d bloggers like this: